by Lexplosion Solution | Feb 19, 2022 | Central, Drugs and medicine, OPS | 0 comments Health Ministry eases norms for manufacture and stocking of new drugs (under Phase III clinical trials) for treating Covid-19 and related diseases You need to be logged in to view this content. Please Log In. Not a Member? Join Us Share this: Share Tweet Pin LinkedIn Related Posts:New Drugs and Clinical Trials Rules amended to…Public comments invited by the Health Ministry on…Public comments invited till 25th April, 2024 on…Health Ministry restricts the manufacture, sale or… centralDrugs and MedicinesOperations Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
